文献速递神经肿瘤功能神经外科

射波刀放射外科在库欣病患者多模式管理中的应用

CyberKnife Radiosurgery in the Multimodal Management of Patients with Cushing Disease.
PubMed 文献 · World Neurosurg · 2018-01-31

这项回顾性研究纳入在斯坦福医院及诊所接受射波刀放射外科治疗活动性库欣病的连续患者,作为经蝶窦手术后持续或复发疾病的辅助治疗。平均随访55.4个月,57.1%的患者高皮质醇血症恢复正常,仅1例(14.2%)出现垂体功能减退,无视觉并发症;手术与放疗间隔<14个月与生化缓解率显著改善相关(P=0.02)。

要点

  • 射波刀作为经蝶窦手术后的辅助治疗,57.1%的患者高皮质醇血症恢复正常。
  • 仅1例(14.2%)出现垂体功能减退,无患者出现视觉并发症。
  • 手术与放疗间隔<14个月与生化缓解率显著改善相关(P=0.02)。

核心结论

  • 在库欣病患者队列中,射波刀是有效的治疗手段,并发症罕见。

研究设计与样本

  • 回顾性研究,纳入在斯坦福医院及诊所接受射波刀放射外科治疗活动性库欣病的连续患者队列。

主要发现

  • 所有患者均先接受经蝶窦手术,组织学证实为促肾上腺皮质激素分泌性垂体腺瘤。
  • 射波刀作为持续或复发疾病的辅助治疗;手术与射波刀之间的中位时间为14 ± 34个月。
  • 射波刀前肿瘤最大径中位数为9 mm(范围7-32 mm),所有患者(100%)存在海绵窦侵犯,1例(14.2%)肿瘤毗邻视交叉。
  • 平均随访55.4个月,4例(57.1%)高皮质醇血症恢复正常:2例(28.5%)下丘脑-垂体-肾上腺轴恢复正常且无需糖皮质激素替代,2例(28.5%)出现肾上腺功能减退。
  • 生化缓解的中位时间为12.5个月;仅1例(14.2%)出现垂体功能减退,无患者出现视觉并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgery is the primary treatment for Cushing disease. When surgery is unsuccessful in normalizing hypercortisolism, adjuvant radiation, such as stereotactic radiosurgery, may be useful to improve biochemical control. METHODS: This retrospective study included a cohort of consecutive patients treated with CyberKnife (CK) radiosurgery for active Cushing disease at Stanford Hospital and Clinics. RESULTS: As first-line treatment, all patients underwent transsphenoidal surgery with histologic demonstration of an adrenocorticotropic hormone-producing pituitary adenoma. CK was performed as adjuvant therapy for persistent or recurrent disease. The median time between surgery and CK was 14 ± 34 months. Before CK, median maximal diameter of tumors was 9 mm (range, 7-32 mm), with cavernous sinus invasion in all patients (100%) and abutment of the optic chiasm in 1 patient (14.2%). With an average follow-up of 55.4 months, normalization of hypercortisolism was achieved in 4 patients (57.1%): 2 patients (28.5%) achieved normalization of the hypothalamic-pituitary-adrenal axis without glucocorticoid replacement, and 2 patients developed hypoadrenalism (28.5%). The median time to biochemical remission was 12.5 months. Hypopituitarism occurred in only 1 patient (14.2%), and no patients had visual complications. Time between surgery and radiotherapy of <14 months was associated with a significantly improved biochemical remission rate (P = 0.02). CONCLUSIONS: In a cohort of patients with Cushing disease, we demonstrate that CK is an effective treatment with rare complications.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Moore JM, Sala E, Amorin A, et al. CyberKnife Radiosurgery in the Multimodal Management of Patients with Cushing Disease. World Neurosurg. 2018. PMID: 29355797. doi:10.1016/j.wneu.2018.01.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。